2025-11-16 - Analysis Report
Okay, here's a report analyzing BlackRock (BLK) based on the provided data.

**Report on BlackRock Inc. (BLK)**

BlackRock Inc. is a multinational investment management corporation.

**1. Performance vs. S&P 500 (VOO)**

*   **Accumulated Return (BLK):** 54.13%
*   **Accumulated Return (VOO):** 98.45%
*   **Return Difference (BLK - VOO):** -44.32%
*   **Relative Deviation:**
    *   **Max:** 32.1
    *   **Min:** -46.4
    *   **Current:** -42.8
    *   **Relative Deviation:** 4.6 (Indicates BLK is positioned towards the lower end of its historical relative performance range compared to VOO)

**Analysis of Alpha, Beta, CAGR, and MDD (2015-2025)**

| Year       | CAGR |  MDD  | Alpha | Beta | Cap(B) |
| :----------- | :---- | :---- | :----- | :--- | :----- |
| 2015-2017  | 48.0% | 61.2% | 20.0%  | -0.0 | 80.6  |
| 2016-2018  | 7.0%  | 68.1% | -9.0%  | -0.2 | 61.6  |
| 2017-2019  | 18.0% | 69.4% | -5.0%  | -0.4 | 78.9  |
| 2018-2020  | -2.0% | 81.8% | -25.0% | -0.3 | 113.2 |
| 2019-2021  | 67.0% | 81.8% | 20.0%  | -0.2 | 143.6 |
| 2020-2022  | -2.0% | 81.8% | -1.0%  | 2.2  | 111.2 |
| 2021-2023  | 6.0%  | 76.8% | 4.0%   | 3.0  | 127.3 |
| 2022-2024  | 24.0% | 78.6% | 3.0%   | 3.1  | 160.8 |
| 2023-2025  | 20.0% | 78.6% | -43.0% | 1.3  | 166.0 |

*   **CAGR:** Varies significantly, reflecting market conditions.  The recent period (2023-2025) shows a 20% CAGR.
*   **MDD:** Consistently high, indicating significant volatility.
*   **Alpha:** Fluctuation indicates periods of both outperformance and underperformance relative to its benchmark.  The most recent period has a significantly negative alpha.
*   **Beta:**  The Beta changes between negative and positive values.
*   **Cap(B):**  Shows a general upward trend, reflecting asset growth under management.

**2. Recent Price Action**

*   **Current Price:** 1057.94
*   **Previous Close:** 1069.65
*   **Change:** -1.09 (-1.09%)
*   **5-day Moving Average:** 1077.98
*   **20-day Moving Average:** 1098.01
*   **60-day Moving Average:** 1126.86

The price is below all three moving averages, indicating a short-term downtrend. The negative change compared to the previous close confirms this.

**3. Technical Indicators and Outlook**

*   **Market Risk Indicator (MRI):** 0.8 (Medium Investment Recommended)
*   **RSI:** 25.51 (Oversold)
*   **PPO:** -0.18
*   **Hybrid Signal:** Suggests a 100% Buy (very safe) strategy, with monthly investment of 0.8% of total investment.
*   **Delta_Previous_Relative_Divergence:** 4.6 (Positive, suggesting a short-term uptrend in relative performance).
*   **Expected Return:** -186.0% (Significant underperformance compared to S&P 500 over a long-term investment horizon)

The current price drop and oversold RSI might suggest a potential short-term buying opportunity. However, the low PPO, negative expected return, and the recent price drop indicate caution.

**4. Recent News & Significant Events**

*   **Harvard Endowment Invests in Bitcoin via BlackRock's IBIT:** This highlights BlackRock's involvement in the growing cryptocurrency market. A substantial investment from a prestigious institution like Harvard could be a positive signal.
*   **Fed Reshuffling:** Potential impacts on monetary policy and market conditions.
*   **Valuation Examination:** Suggests the share price pullback warrants a review of BlackRock's valuation.
*   **Sonder Collapse:** BlackRock's involvement in the Sonder situation could negatively impact investor sentiment.

**4-2. Analyst Opinions**

*   **Consensus:** Buy (Mean rating: 1.59)
*   **Target Price:** $1334.00 (Significant upside potential)

Analysts remain generally positive on BlackRock, with a consensus "Buy" rating and a substantial target price above the current level.

**5. Recent Earnings Analysis**

| Date       | EPS  | Revenue  |
| :---------- | :---- | :-------- |
| 2024-08-06 | 10.07 | 4.80 B$ |
| 2024-05-07 | 10.58 | 4.73 B$ |
| 2023-11-06 | 10.75 | 4.52 B$ |
| 2023-08-04 | 9.13  | 4.46 B$ |
| 2024-08-06 | 9.13  | 4.46 B$ |

*   EPS shows some volatility.
*   Revenue generally trending upwards.

**6. Financial Information (Revenue & Profitability, Capital & Profitability)**

| Quarter    | Revenue   | Profit Margin |
| :----------- | :--------- | :-------------- |
| 2025-09-30 | \$6.51B   | 45.94%          |
| 2025-06-30 | \$5.42B   | 47.87%          |
| 2025-03-31 | \$5.28B   | 47.88%          |
| 2024-12-31 | \$5.68B   | 49.25%          |
| 2024-09-30 | \$5.20B   | 51.13%          |

| Quarter    | Equity    | ROE     |
| :----------- | :---------- | :------- |
| 2025-09-30 | \$55.52B  | 2.38%   |
| 2025-06-30 | \$49.14B  | 3.24%   |
| 2025-03-31 | \$48.04B  | 3.14%   |
| 2024-12-31 | \$47.49B  | 3.52%   |
| 2024-09-30 | \$41.18B  | 3.96%   |

*   **Revenue:** Increasing trend over the last five quarters.
*   **Profit Margin:** Relatively stable, but showing a slight decrease recently.
*   **Equity:** Increasing, indicating growth in the company's net assets.
*   **ROE:** Decreasing, indicating less efficient use of equity to generate profits.

**7. Summary and Conclusion**

BlackRock is experiencing a period of mixed signals. While revenue and equity are growing, profit margins and ROE are declining. The stock price is currently in a short-term downtrend and is underperforming the S&P 500. However, recent news suggests that it may have a chance of rapid growth due to Harvard's investment, and positive analyst ratings with high target prices offer optimism.

*   **Positive:** Harvard's investments related to Bitcoin ETFs, growing revenue, positive long-term analyst outlook.
*   **Negative:** Short-term price weakness, decline in ROE, negative expected return compared to S&P 500.

The mixed outlook suggests a "Hold" or "Cautious Buy" strategy might be appropriate. Investors should carefully consider their risk tolerance, investment horizon, and the company's long-term growth prospects before making a decision. Further monitoring of BlackRock's performance and market conditions is recommended.
